Neurocrine Biosciences
David Chew currently serves as a Senior Specialist in R&D Strategic Operations at Neurocrine Biosciences since November 2023. Prior to this role, David worked at Takeda as a Specialist in CDMO Relationship Management from December 2019 to November 2023. David has a strong background in research and development, having held positions as a Research Associate II at Wave Life Sciences, a Chemist II at Merck, and an Associate Scientist I at GENEWIZ. Throughout these positions, David has been responsible for the synthesis, optimization, purification, and analysis of heavily modified oligonucleotides, utilizing various automated synthesizers. David earned a Bachelor of Arts in Cell Biology and Neuroscience from Rutgers University, completing the degree in 2015.
This person is not in any teams
This person is not in any offices